Older female mice, equivalent in age to 60-year-old women, lived about 12 percent longer when given daily injections of the active ingredient in Ozempic compared to mice that did not receive the drug.
Notes on verification
Confirmed by peer-reviewed Nature study, NIH press release, and multiple independent science outlets reporting consistent figures (834 vs 742 days, 12% increase) and age-equivalence framing. [tier=gold indep_score=1.0 clusters=4 claim_tier=notable]
Sources
- Smart News: Science News - Smithsonian Magazine (seed:science_and_space)
- https://www.nature.com/articles/d41586-026-02757-1 (corroboration)
- https://www.nih.gov/news-events/news-releases/glp-1-treatment-late-life-extends-lifespan-animal-model (corroboration)
- https://www.scientificamerican.com/article/glp-1-weight-loss-medication-could-slow-aging-and-extend-lifespan/ (corroboration)
- https://cen.acs.org/biological-chemistry/semaglutide-mouse-longevity/104/web/2026/09 (corroboration)
- https://www.nature.com/articles/s41586-026-10940-7 (corroboration)